Top Phoenix, AZ Biotech Companies (26)
Don't see your company?
Create a company profile
Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM). Dexcom began as a small company with a big dream: To forever change how diabetes is managed. To unlock information and insights that drive better health outcomes. Here we are 25 years later, having pioneered an industry. And we're just getting started. We are broadening our vision beyond diabetes to empower people to take control of health. That means personalized, actionable insights aimed at solving important health challenges. To continue what we've started: Improving human health. We are driven by over 10,000 ambitious, passionate people worldwide who are willing to fight like warriors to earn the trust of our customers by listening, serving with integrity, thinking big, and being dependable. We've already changed millions of lives and we're ready to change millions more. Our future ambition is to become a leading consumer health technology company while continuing to develop solutions for serious health conditions. We'll get there by constantly reinventing unique biosensing-technology experiences. Though we've come a long way from our small company days, our dreams are bigger than ever. The opportunity to improve health on a global scale stands before us
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with our customers, we are driven to make healthcare better.
RiboMed Biotechnologies is a molecular diagnostic company.
Twenty years ago, we pioneered the world's first clear aligners. Since then, we have continuously innovated with new products and technologies that are revolutionizing treatments for doctors and their patients. Invisalign clear aligners and the iTero Intraoral scanner help dental professionals achieve the clinical results they expect and deliver effective, advanced dental options to their patients. Helping change millions of lives, one smile at a time. Discover your straight path to a bright future at Align. As a part of our smart, diverse and fast-moving global team, you'll make an impact for the market leader that's moving an industry forward. Want to find out what’s next for us—and for you?
.jpg)
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.
MTI was established as a research and development company with a mission of developing a wide variety of products.
A regenerative medicine company focused on the body performing optimally
To use Susavion’s patented MultiValent Peptide Mimetic (MVPM) Technology platform to harness the innate power of the immune system to combat diseases with non-toxic, safe and effective treatments. At Susavion, we pride ourselves on doing things differently. We’re at the forefront of scientific innovation, leading the charge in the effort to solve some of healthcare’s most intractable problems. Our revolutionary therapy is safe and nontoxic, and we care about the people our research will benefit—always balancing our cutting-edge technology with our humanity.
Discover the benefits of Nucleic Acid Programmable Protein Arrays(NAPPA). The Ordinatrix team includes co-founders Prof. Josh LaBaer and Prof. Ji Qiu from Arizona State University, joined with biotech/life science executive Jim Hauert. Our goal is to be the leader in translational proteomics through the creation of the most functional, flexible, and precise protein microarrays in the industry based on our attention to quality, intellectual property, and many years of experience with the Nucleic Acid Programmable Protein Arrays (NAPPA) technology, which will aid in the development of new drugs, diagnosis of disease and approaches to personalized medicine.
A precision medicine company with novel technology enabling advanced diagnostics and biomarker discovery
Humabiologics is a regenerative medicine startup to address the gap between the gift of donated human tissues and researchers.
We focus on genomic technologies and provide complete solutions for gene profiling and screening for all life science applications. By means of integrating high-throughput laboratory and microarray fabrication facilities, GenoSensor has become a nationwide leading company in bioassay services and development. Our COVID-19 test kit assays 3 target genes unique to SARS-CoV-2 having higher specificity and exhibiting lower risk for mutation. Our kit is simple to use and ready to utilize in all-in-one master mix reagents and controls minimize variability.
OncoMyx Therapeutics targets hematologic and solid tumors with unique oncolytic virus called myxoma (MYXV) and a novel patented systemic delivery approach. The myxoma program is the result of two decades of oncolytic virus research in the laboratory of Professor Grant McFadden. Myxoma is a pox virus that is highly immunostimulatory, and is non-pathogenic in any organism outside of rabbits. The virus has a unique ability to be carried systemically by human leukocytes where it can then infect tumor cells. Programs are in development for both hematology (myeloma and AML) as well as solid tumors. Professor McFadden sequenced the myxoma virus genome in 1999, and since then has produced dozens of genetically engineered constructs, demonstrating its ability as an oncolytic agent across many tumors in preclinical cell and animal models.
Science Care is a biotechnology firm specializing in human tissue for medical research, training and professional education.
Beacon Biomedical is a biotech company, focuses on developing and commercializing waived tests for earlier cancer detection.
Amnio Technology is a company based out of 22510 N 18TH DR, PHOENIX, Arizona, United States.
TGen, an affiliate of City of Hope, is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics and treatments for cancer, neurological disorders, rare childhood disorders, infectious disease and other complex conditions. Stay up-to-date: tgen.org/subscribe
Systems Oncology is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our Arromer platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex polygenic disease.
PanTheryx™ is the leading nutrition and biotechnology company committed to the global commercialization of bovine colostrum-based health and wellness solutions. From establishing ourselves as the world’s premier supplier of colostrum, to driving cutting edge research, to commercializing novel solutions, we are dedicated to harnessing the power of nature’s superfood to develop revolutionary approaches to human and animal health.
Work Your Passion. Live Your Purpose.
